197 related articles for article (PubMed ID: 33091232)
1. Electrophysiological characterization of the modified hERG
Zhang Y; Dempsey CE; Hancox JC
Physiol Rep; 2020 Oct; 8(20):e14568. PubMed ID: 33091232
[TBL] [Abstract][Full Text] [Related]
2. Serine mutation of a conserved threonine in the hERG K
Al-Moubarak E; Zhang Y; Dempsey CE; Zhang H; Harmer SC; Hancox JC
Biochem Biophys Res Commun; 2020 Jun; 526(4):1085-1091. PubMed ID: 32321643
[TBL] [Abstract][Full Text] [Related]
3. Action potential clamp characterization of the S631A hERG mutation associated with short QT syndrome.
Butler A; Zhang Y; Stuart AG; Dempsey CE; Hancox JC
Physiol Rep; 2018 Sep; 6(17):e13845. PubMed ID: 30175559
[TBL] [Abstract][Full Text] [Related]
4. Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome.
Butler A; Zhang Y; Stuart AG; Dempsey CE; Hancox JC
Heliyon; 2019 Apr; 5(4):e01429. PubMed ID: 31049424
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the hERG potassium channel by phenanthrene: a polycyclic aromatic hydrocarbon pollutant.
Al-Moubarak E; Shiels HA; Zhang Y; Du C; Hanington O; Harmer SC; Dempsey CE; Hancox JC
Cell Mol Life Sci; 2021 Dec; 78(23):7899-7914. PubMed ID: 34727194
[TBL] [Abstract][Full Text] [Related]
6. Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG 'hotspot' mutation.
Du C; Zhang H; Harmer SC; Hancox JC
Biochem Biophys Res Commun; 2022 Mar; 596():49-55. PubMed ID: 35114584
[TBL] [Abstract][Full Text] [Related]
7. Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration.
Melgari D; Du C; El Harchi A; Zhang Y; Hancox JC
Physiol Rep; 2014 Oct; 2(10):. PubMed ID: 25318749
[TBL] [Abstract][Full Text] [Related]
8. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
Ridley JM; Milnes JT; Hancox JC; Witchel HJ
J Mol Cell Cardiol; 2006 Jan; 40(1):107-18. PubMed ID: 16288909
[TBL] [Abstract][Full Text] [Related]
9. Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel.
El Harchi A; Melgari D; Zhang YH; Zhang H; Hancox JC
PLoS One; 2012; 7(12):e52451. PubMed ID: 23300672
[TBL] [Abstract][Full Text] [Related]
10. Structural implications of hERG K
Helliwell MV; Zhang Y; El Harchi A; Du C; Hancox JC; Dempsey CE
J Biol Chem; 2018 May; 293(18):7040-7057. PubMed ID: 29545312
[TBL] [Abstract][Full Text] [Related]
11. Altered gating of HERG potassium channels by cobalt and lanthanum.
Sanchez-Chapula JA; Sanguinetti MC
Pflugers Arch; 2000 Jun; 440(2):264-74. PubMed ID: 10898527
[TBL] [Abstract][Full Text] [Related]
12. Ranolazine inhibition of hERG potassium channels: drug-pore interactions and reduced potency against inactivation mutants.
Du C; Zhang Y; El Harchi A; Dempsey CE; Hancox JC
J Mol Cell Cardiol; 2014 Sep; 74(100):220-30. PubMed ID: 24877995
[TBL] [Abstract][Full Text] [Related]
13. Fluid flow modulates electrical activity in cardiac hERG potassium channels.
Roy S; Mathew MK
J Biol Chem; 2018 Mar; 293(12):4289-4303. PubMed ID: 29305421
[TBL] [Abstract][Full Text] [Related]
14. The Susceptibilities of Human Ether-à-Go-Go-Related Gene Channel with the G487R Mutation to Arrhythmogenic Factors.
Hisajima N; Hata Y; Kinoshita K; Fukushima T; Nishida N; Kano M; Tabata T
Biol Pharm Bull; 2015; 38(5):781-4. PubMed ID: 25947924
[TBL] [Abstract][Full Text] [Related]
15. Interactions between amiodarone and the hERG potassium channel pore determined with mutagenesis and in silico docking.
Zhang Y; Colenso CK; El Harchi A; Cheng H; Witchel HJ; Dempsey CE; Hancox JC
Biochem Pharmacol; 2016 Aug; 113():24-35. PubMed ID: 27256139
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological evaluation of an anticancer drug gemcitabine on cardiotoxicity revealing down-regulation and modification of the activation gating properties in the human rapid delayed rectifier potassium channel.
Wei M; Wang P; Zhu X; Morishima M; Liu Y; Zheng M; Liu G; Osanai H; Yoshimura K; Kume S; Kurokawa T; Ono K
PLoS One; 2023; 18(2):e0280656. PubMed ID: 36730356
[TBL] [Abstract][Full Text] [Related]
17. Cryo-EM Structure of the Open Human Ether-à-go-go-Related K
Wang W; MacKinnon R
Cell; 2017 Apr; 169(3):422-430.e10. PubMed ID: 28431243
[TBL] [Abstract][Full Text] [Related]
18. Differential Regulation of Human Ether-à-Go-Go-Related Gene (hERG) Current and Expression by Activation of Protein Kinase C.
Sutherland-Deveen ME; Wang T; Lamothe SM; Tschirhart JN; Guo J; Li W; Yang T; Du Y; Zhang S
Mol Pharmacol; 2019 Jul; 96(1):1-12. PubMed ID: 31015282
[TBL] [Abstract][Full Text] [Related]
19. New aspects of HERG K⁺ channel function depending upon cardiac spatial heterogeneity.
Zhang P; Guan P; Bai XL; Song ZP
PLoS One; 2014; 9(1):e72181. PubMed ID: 24475014
[TBL] [Abstract][Full Text] [Related]
20. Time course and voltage dependence of expressed HERG current compared with native "rapid" delayed rectifier K current during the cardiac ventricular action potential.
Hancox JC; Levi AJ; Witchel HJ
Pflugers Arch; 1998 Nov; 436(6):843-53. PubMed ID: 9799397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]